Clinical Trials Browser

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT07446660 2026-03-23

STEP2 RNT

Phase NA Not yet recruiting

652 enrolled

Tumor-Agnostic

Neoplasms

NCT07487298 2026-03-23

G8-PT

Not yet recruiting

150 enrolled

Frailty, Neoplasms

NCT07487805 2026-03-23

ICONIC

Phase 2 Not yet recruiting

80 enrolled

Tumor-Agnostic

Neoplasms

NCT07484932 2026-03-20

TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer

Phase NA Not yet recruiting

400 enrolled

Tumor-Agnostic

Neoplasms

NCT07476443 2026-03-17

VitC-CoQ10

Phase 2/3 Not yet recruiting

75 enrolled

Tumor-Agnostic

Neoplasms

NCT07474025 2026-03-16

Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses

Not yet recruiting

30 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07454031 2026-03-13

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Phase 1 Not yet recruiting

22 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT07471009 2026-03-13

SPAR

Not yet recruiting

120 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT07471425 2026-03-13

TOLERATE

Not yet recruiting

1,100 enrolled

Tumor-Agnostic

Neoplasms

NCT07296887 2026-03-12

CARE Tool Study Aim 3

Phase NA Not yet recruiting

430 enrolled

GastrointestinalGenitourinaryThoracic

Financial Stress, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07466212 2026-03-12

QoLIDia

Not yet recruiting

920 enrolled

Diabetes Mellitus, Type 2, Neoplasms

Clinical Trials

The Comparative Effectiveness Evaluation of the Impact of Digital Education

Using e-Technologies to Maximize Physical Activity After Cancer Treatment

AI-ChemoApp

Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center

DMU-CH

eQuoL Effectiveness Study

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

FMT-CACH

IMPULSION

AspiRe HCC

RI-LieF

Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

EQUICAP

FITCAN

Effect of Meal Timing During Adjuvant Treatment for Cancer

CARES-Lite

SHAPE-ENDO

ASPIRE AI

ECO 2

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

ART-Hypo

Personalized Cooking and Nutrition Guidance and Physical Activities Program to Reduce Muscle Loss in Advanced Cancer

Information-providing Chatbot

Evaluation of a Mobile App Program for Coping With Cancer

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

CHAS3

RELI

IMPACT

A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）

HERA

Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients

Behavioral Pain Intervention for Older Cancer Patients

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

QUALISENS

SPPC

ACCESS-PC

STEP2 RNT

G8-PT

ICONIC

TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer

VitC-CoQ10

Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

SPAR

TOLERATE

CARE Tool Study Aim 3

QoLIDia